Evidence map›Paper›PMID 27741356›Full record

ArticleThe Journal of pathology2017

MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer.

Yan Sun, Ping Ji, Tao Chen, Xinhui Zhou, Da Yang, Yuhong Guo, Yuexin Liu, Limei Hu, Dianren Xia, Yanxue Liu and 8 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Yan Sun *Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Ping Ji *Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Tao ChenDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Xinhui ZhouDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Da YangDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Yuhong GuoDepartment of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Yuexin LiuDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Limei HuDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Dianren XiaDepartment of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Yanxue LiuDepartment of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Asha S MultaniDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Ilya ShmulevichInstitute for Systems Biology, Seattle, WA 98103, USA.
Raju KucherlapatiDepartments of Genetics and Medicine, Harvard Medical School, Boston, MA 02115, USA.
Scott KopetzDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Anil K SoodDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Stanley R HamiltonDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Baocun SunDepartment of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Wei ZhangDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
The University of Texas MD Anderson Cancer Center · USTianjin Medical University Cancer Institute and Hospital · CNAtrium Health Wake Forest Baptist · USHarvard University · USInstitute for Systems Biology · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Harvard Genome Characterization CenterU24CA144025 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI KUCHERLAPATI, RAJU S. · 2009 to 2016
$14.0M
Center for Systems Analysis of the Cancer RegulomeU24CA143835 · NCI · INSTITUTE FOR SYSTEMS BIOLOGY · PI SHMULEVICH, ILYA · 2009 to 2016
$10.6M
NCI NIH HHS P30 CA016672NCI NIH HHS U24 CA143835NCI NIH HHS U24 CA144025
6 · The paper itself

Abstract

The gene encoding migration and invasion inhibitory protein (MIIP), located on 1p36.22, is a potential tumour suppressor gene in glioma. In this study, we aimed to explore the role and mechanism of action of MIIP in colorectal cancer (CRC). MIIP protein expression gradually decreased along the colorectal adenoma-carcinoma sequence and was negatively correlated with lymph node and distant metastasis in 526 colorectal tissue samples (p < 0.05 for all). Analysis of The Cancer Genome Atlas (TCGA) data showed that decreased MIIP expression was significantly associated with MIIP hemizygous deletion (p = 0.0005), which was detected in 27.7% (52/188) of CRC cases, and associated with lymph node and distant metastasis (p < 0.05 for both). We deleted one copy of the MIIP gene in HCT116 CRC cells using zinc finger nuclease technology and demonstrated that MIIP haploinsufficiency resulted in increased colony formation and cell migration and invasion, which was consistent with the results from siRNA-mediated MIIP knockdown in two CRC cell lines (p < 0.05 for all). Moreover, MIIP haploinsufficiency promoted CRC progression in vivo (p < 0.05). Genomic instability and spectral karyotyping assays demonstrated that MIIP haploinsufficiency induced chromosomal instability (CIN). Besides modulating the downstream proteins of APC/C

Indexed as

AdenocarcinomaAnimalsCarrier ProteinsCell MovementCell Transformation, NeoplasticChromosomal InstabilityColorectal NeoplasmsDisease ProgressionDown-RegulationFemaleGene DeletionHaploinsufficiencyHumansIntracellular Signaling Peptides and ProteinsMaleMice, NudeCarrier ProteinsIntracellular Signaling Peptides and ProteinsMIIP protein, humanNeoplasm Proteinschromosomal instabilitycolorectal cancerMIIPprogressiontopoisomerase

Identifiers

PMID27741356
PMCPMC5315452
OpenAlexW2533701901

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.